skip to content

Roche's Half-Year Results 2025 Presentation

Roche has published its Half-Year Results for 2025 prior to the opening of the Swiss Stock Exchange on Thursday, 24 July 2025.

Agenda
OverviewThomas Schinecker, CEO Roche Group
Financial ResultsAlan Hippe, Chief Financial and IT Officer
Pharmaceuticals DivisionTeresa Graham, CEO Roche Pharmaceuticals
Diagnostics DivisionMatt Sause, CEO Roche Diagnostics
Q&ABruno Eschli, Head of Investor Relations

Webinar Replay

Investors

Past IR Events
View more Events